Resting state functional connectivity patterns as biomarkers of treatment response to escitalopram in patients with major depressive disorder

Resting state functional connectivity patterns as biomarkers of treatment response to escitalopram in patients with major depressive disorder

<strong>Rational<br></strong> With no available response biomarkers, matching an appropriate antidepressant to an individual can be a lengthy process. Improving understanding of processes underlying treatment responsivity in depression is crucial for facilitating work on response...

Полное описание

Библиографические подробности
Главные авторы:	Martens, MAG, Filippini, N, Harmer, CJ, Godlewska, BR
Формат:	Journal article
Язык:	English
Опубликовано:	Springer Nature 2021

Схожие документы

Effects of escitalopram therapy on functional brain controllability in major depressive disorder
по: Fang, F, и др.
Опубликовано: (2022)

Functional connectivity between task-positive networks and the left precuneus as a biomarker of response to lamotrigine in bipolar depression: a pilot study
по: Martens, M, и др.
Опубликовано: (2021)

Comparative efficacy of escitalopram in the treatment of major depressive disorder
по: Mazen K Ali, и др.
Опубликовано: (2011-02-01)

Short-term escitalopram treatment normalizes aberrant self-referential processing in major depressive disorder
по: Komulainen, E, и др.
Опубликовано: (2018)

Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy
по: Mencacci C, и др.
Опубликовано: (2013-02-01)

Effective connectivity between resting-state networks in depression
по: DeMaster, D, и др.
Опубликовано: (2022)

Functional neuroimaging biomarkers of anhedonia response to escitalopram plus adjunct aripiprazole treatment for major depressive disorder
по: Sophie R. Vaccarino, и др.
Опубликовано: (2024-01-01)

Cognitive neuropsychological theory of antidepressant action: A modern-day approach to depression and its treatment
по: Godlewska, BR, и др.
Опубликовано: (2020)

A Comparative Study of Efficacy and Safety of Agomelatine and Escitalopram in Major Depressive Disorder
по: Ravi Babu. Komaram, и др.
Опубликовано: (2015-06-01)

Functional Connectivity between Task-Positive Networks and the Left Precuneus as a Biomarker of Response to Lamotrigine in Bipolar Depression: A Pilot Study
по: Marieke Martens, и др.
Опубликовано: (2021-06-01)

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
по: Kishi T, и др.
Опубликовано: (2017-01-01)

Modulatory interactions of resting-state brain functional connectivity in major depressive disorder
по: Tu Z, и др.
Опубликовано: (2018-09-01)

Multivariate pattern analysis strategies in detection of remitted major depressive disorder using resting state functional connectivity
по: Runa Bhaumik, и др.
Опубликовано: (2017-01-01)

Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder
по: Dominika Jarčušková, и др.
Опубликовано: (2024-10-01)

Fabrication and Characterization of Fast-Dissolving Films Containing Escitalopram/Quetiapine for the Treatment of Major Depressive Disorder
по: Manal E. Alkahtani, и др.
Опубликовано: (2021-06-01)

Escitalopram-induced akathisia in a patient with major depressive disorder: A rare case report
по: Hareem Arshad, и др.
Опубликовано: (2022-11-01)

Escitalopram for the management of major depressive disorder: a review of its efficacy, safety, and patient acceptability
по: Kirino E
Опубликовано: (2012-12-01)

Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
по: Maneeton B, и др.
Опубликовано: (2018-08-01)

Escitalopram enhances synchrony of brain responses during emotional narratives in patients with major depressive disorder
по: Emma Komulainen, и др.
Опубликовано: (2021-08-01)

Aberrant resting‐state functional connectivity of major depressive disorder with higher risk of suicide
по: Kazuhiro Ishikawa MD, и др.
Опубликовано: (2022-09-01)

Decreased resting-state functional connectivity of the habenula-cerebellar in a major depressive disorder
по: Ju-Yeon Jung, и др.
Опубликовано: (2022-09-01)

Abnormal resting-state functional connectivity of hippocampal subfields in patients with major depressive disorder
по: Zi Yu Hao, и др.
Опубликовано: (2020-02-01)

Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis
по: Juntao Yin, и др.
Опубликовано: (2023-11-01)

Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
по: Huang J, и др.
Опубликовано: (2018-09-01)

Abnormal resting-state functional connectivity in subregions of amygdala in adults and adolescents with major depressive disorder
по: Lin Guan, и др.
Опубликовано: (2024-07-01)

Longitudinal effects of antidepressant treatment on resting state functional connectivity in adolescents with major depressive disorder
по: K.H. Lee, и др.
Опубликовано: (2022-06-01)

Individualized resting-state functional connectivity abnormalities unveil two major depressive disorder subtypes with contrasting abnormal patterns of abnormality
по: Keke Fang, и др.
Опубликовано: (2025-02-01)

Efficacy and safety of generic escitalopram (Lexacure®) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram-comparative, non-inferiority study
по: Jeong JH, и др.
Опубликовано: (2015-10-01)

Comparison of the Effect of Sertraline and Escitalopram on the Treatment of Major Depressive Disorder in Hemodialysis Patients: A Randomized Controlled Trial
по: Tahereh Sabaghian, и др.
Опубликовано: (2024-09-01)

Review of the brain areas activated in fMRI after escitalopram antidepressant treatment inpatients with major depressive disorder
по: Mao Yi, и др.
Опубликовано: (2021-08-01)

Treatment of alcohol dependence in patients with co-morbid major depressive disorder – predictors for the outcomes with memantine and escitalopram medication
по: Lönnqvist Jouko, и др.
Опубликовано: (2008-10-01)

Impact of gender, depression severity and type of depressive episode on efficacy and safety of escitalopram: an observational study on major depressive disorder patients in southern India
по: Tatiyana Mandal, и др.
Опубликовано: (2021-03-01)

Short-term escitalopram treatment and hippocampal volume.
по: Godlewska, B, и др.
Опубликовано: (2014)

A Study about Escitalopram Versus Citalopram in the Treatment of Depressive Disorders
по: Jasim M. Shindi, и др.
Опубликовано: (2015-08-01)

Alterations in electroencephalographic functional connectivity in individuals with major depressive disorder: a resting-state electroencephalogram study
по: Yingtan Wang, и др.
Опубликовано: (2024-07-01)

Resting-state functional connectivity of the raphe nuclei in major depressive Disorder: A Multi-site study
по: Yajuan Zhang, и др.
Опубликовано: (2023-01-01)

Efficacy and safety of repeated transcranial magnetic stimulation combined with escitalopram in the treatment of major depressive disorder: a meta-analysis
по: Zhang Liu, и др.
Опубликовано: (2024-01-01)

An Open-Label Rater-Blinded Randomized Trial of Vilazodone versus Escitalopram in Major Depression
по: Pattath Narayanan Suresh Kumar, и др.
Опубликовано: (2023-01-01)

CYP2C19 polymorphisms and outcomes of Escitalopram treatment in Brazilians with major depression
по: Rodrigo Bernini de Brito, и др.
Опубликовано: (2020-05-01)

Baseline patterns of resting functional connectivity within posterior default-mode intranetwork associated with remission to antidepressants in major depressive disorder
по: Yanxiang Ye, и др.
Опубликовано: (2022-01-01)